LLY

885.52

+0.86%↑

JNJ

242.36

+0.87%↑

ABBV

213.25

+1.7%↑

NVS

150.37

+1.43%↑

MRK

117.85

-1.53%↓

LLY

885.52

+0.86%↑

JNJ

242.36

+0.87%↑

ABBV

213.25

+1.7%↑

NVS

150.37

+1.43%↑

MRK

117.85

-1.53%↓

LLY

885.52

+0.86%↑

JNJ

242.36

+0.87%↑

ABBV

213.25

+1.7%↑

NVS

150.37

+1.43%↑

MRK

117.85

-1.53%↓

LLY

885.52

+0.86%↑

JNJ

242.36

+0.87%↑

ABBV

213.25

+1.7%↑

NVS

150.37

+1.43%↑

MRK

117.85

-1.53%↓

LLY

885.52

+0.86%↑

JNJ

242.36

+0.87%↑

ABBV

213.25

+1.7%↑

NVS

150.37

+1.43%↑

MRK

117.85

-1.53%↓

Search

Quanterix Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

3.43 -3.92

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.35

Max

3.57

Pagrindiniai rodikliai

By Trading Economics

Pajamos

10M

-23M

Pardavimai

3.7M

44M

Pelno marža

-52.712

Darbuotojai

450

EBITDA

15M

-17M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+109.5% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-05-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-111M

185M

Ankstesnė atidarymo kaina

7.35

Ankstesnė uždarymo kaina

3.43

Naujienos nuotaikos

By Acuity

50%

50%

153 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Quanterix Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-27 17:33; UTC

Svarbiausios naujienos

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

2026-03-27 17:00; UTC

Svarbiausios naujienos

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

2026-03-27 16:03; UTC

Svarbiausios naujienos

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

2026-03-29 23:47; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Falls Amid Rising Inflation Fears -- Market Talk

2026-03-29 23:46; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Nikkei May Fall on Fears About Shortage of Petrochemical Products -- Market Talk

2026-03-29 23:35; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Rises on Supply-Disruption Concerns Spurred by Widening Mideast Conflict -- Market Talk

2026-03-29 23:23; UTC

Rinkos pokalbiai

Australia's National Cabinet to Avoid Covid-Style Measures -- Market Talk

2026-03-29 22:34; UTC

Rinkos pokalbiai

Macroeconomic Tailwind for Warehouse Dissipates -- Market Talk

2026-03-29 22:09; UTC

Rinkos pokalbiai

Amplitude's Next Well "Effectively a Must-Win" for Growth Thesis -- Market Talk

2026-03-29 21:06; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Australia's Economy Could Already Be Contracting Amid Oil Shock -- Market Talk

2026-03-29 21:03; UTC

Rinkos pokalbiai

Australia's Government Wants to Avoid Heavy Handed Oil Shock Response -- Market Talk

2026-03-29 21:01; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Australian National Cabinet Meeting to Focus on Oil Supply -- Market Talk

2026-03-29 09:30; UTC

Įsigijimai, susijungimai, perėmimai

Food Mega-Mergers Hardly Ever Work. Could McCormick-Unilever Be Different? -- Heard on the Street -- WSJ

2026-03-28 08:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-27 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-27 19:16; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

2026-03-27 19:07; UTC

Rinkos pokalbiai

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

2026-03-27 19:04; UTC

Rinkos pokalbiai

Gold Rises But Can't Finish the Week Positive -- Market Talk

2026-03-27 19:03; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Forex and Fixed Income Roundup: Market Talk

2026-03-27 19:02; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

2026-03-27 18:12; UTC

Rinkos pokalbiai

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

2026-03-27 17:36; UTC

Svarbiausios naujienos

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

2026-03-27 17:34; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

2026-03-27 17:29; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

2026-03-27 16:38; UTC

Rinkos pokalbiai

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

2026-03-27 16:32; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

2026-03-27 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-27 15:43; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

2026-03-27 15:25; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-27 15:25; UTC

Rinkos pokalbiai

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

Akcijų palyginimas

Kainos pokytis

Quanterix Corp Prognozė

Kainos tikslas

By TipRanks

109.5% į viršų

12 mėnesių prognozė

Vidutinis 7.5 USD  109.5%

Aukščiausias 8 USD

Žemiausias 7 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Quanterix Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

2 ratings

0

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

5.34 / 6.015Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

153 / 349 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat